PET/CT for the assessment and quantification of 90Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases

  • Matthias K. Werner
  • Klaus Brechtel
  • Thomas Beyer
  • Helmut Dittmann
  • Christina Pfannenberg
  • Jürgen Kupferschläger
Letter to the Editor

References

  1. 1.
    Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Bilbao J, et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 2009;36:1696.CrossRefPubMedGoogle Scholar
  2. 2.
    Ford KW. Predicted 0+ level in 40Zr90*. Phys Rev 1955;98:1516–17.CrossRefGoogle Scholar
  3. 3.
    Greenberg JS, Deutsch M. Positrons from the decay of P32 and Y90. Phys Rev 1956;102:415–21.CrossRefGoogle Scholar
  4. 4.
    Nickles RJ, Roberts AD, Nye JA, Converse AK, Barnhart TE, Avila-Rodriguez MA. Assaying and PET imaging of yttrium-90: 1>>34 ppm>0. IEEE Nucl Sci Symp Conf Rec 2004;6:3412–14.CrossRefGoogle Scholar
  5. 5.
    Tehranipour N, AL-Nahhas A, Canelo R, Stamp G, Woo K, Tait P, et al. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology. Clin Nucl Med 2007;32:371–74.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Matthias K. Werner
    • 1
  • Klaus Brechtel
    • 1
  • Thomas Beyer
    • 3
  • Helmut Dittmann
    • 2
  • Christina Pfannenberg
    • 1
  • Jürgen Kupferschläger
    • 2
  1. 1.Department of Diagnostic and Interventional RadiologyEberhard-Karls-University Medical CenterTübingenGermany
  2. 2.Nuclear MedicineEberhard-Karls-University Medical CenterTübingenGermany
  3. 3.Imaging Science Institute (ISI) TübingenEberhard-Karls-University Medical CenterTübingenGermany

Personalised recommendations